Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Pulse Biosciences, Inc. | plse-20210331xex31_2.htm |
| EX-31.1 - EX-31.1 - Pulse Biosciences, Inc. | plse-20210331xex31_1.htm |
| 10-Q - 10-Q - Pulse Biosciences, Inc. | plse-20210331x10q.htm |
Exhibit 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Pulse Biosciences, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
In Witness Whereof, the undersigned have set their hands hereto as of the 10th day of May 2021.
|
|
|
|
|
|
|
|
/s/ Darrin R. Uecker |
|
|
|
|
Darrin R. Uecker |
|
|
|
|
President and Chief Executive Officer |
|
|
|
|
(Principal Executive Officer) |
|
|
|
|
/s/ Sandra A. Gardiner |
|
|
|
|
Sandra A. Gardiner |
|
|
|
|
Chief Financial Officer, Executive Vice President of Finance and Administration, Secretary and Treasurer |
|
|
|
|
(Principal Financial and Accounting Officer) |
|
This certification is deemed furnished and not filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Pulse Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this report, irrespective of any general incorporation language contained in such filing.